Spot Dx — What’s behind these shin spots?
Gerald is a 52-year-old IT technician who presents with a six-month history of otherwise asymptomatic pigmented spots on his shins. Test your clinical know-how by…
Tag: Diabetes
Stem-cell treatment for T1DM brings ‘real hope’ as patients achieve insulin independence
Ten people with type 1 diabetes have been “cured” in a phase II trial of a stem-cell treatment. A year after a one-time infusion to…
The GP wound care scheme is an important first step in stopping a hidden epidemic
The Chronic Wound Consumables Scheme (CWCS) promises to offer financial relief to around 20,000 Australians living with chronic wounds. As the country’s peak body for…
New gestational diabetes guidelines set higher glucose thresholds for diagnosis
The first update to gestational diabetes guidelines in a decade has raised the glucose thresholds for diagnosis, aiming to reduce over-medicalisation for women with low-risk…
Daily pill looming for GLP-1 receptor agonists? Eli Lilly drafting TGA application
Eli Lilly is preparing a TGA application for an oral GLP-1 receptor agonist to treat early diabetes following publication of phase III trial results. The…
Band-Aid fixed? Govt launches GP wound care scheme to fund dressings for 20,000 patients
Some 20,000 older patients with diabetes will be eligible for free dressings each year under a long-awaited Federal Government scheme. For years, doctors have warned…
A rapid deterioration follows DKA discharge
Nikki, a slightly built 30-year-old woman with a 10-year history of type 1 diabetes, is brought to ED by ambulance with an altered level of…
What is the new ‘type 5 diabetes’ and did a British doctor in Jamaica predict it in 1955?
How many types of diabetes do you know? The International Diabetes Federation has just recognised type 5 diabetes: a form of severe insulin-deficient diabetes where long-term nutrient deficiencies…
‘Shrunken pore syndrome’ flags mortality risk in T2DM: Aussie study
A low ratio of cystatin C–based eGFR to creatinine-based eGFR in people with type 2 diabetes is linked to mortality regardless of conventional markers of…
Semaglutide associated with vision loss in large observational study
A retrospective cohort study has linked semaglutide to double the risk of serious optic neuropathy in type 2 diabetes patients. Published in JAMA Ophthalmology, the…
